RlapsRisk BC
CE-IVDR-cleared AI diagnostic test that predicts breast-cancer recurrence risk from routine pathology data, spun out of Owkin's diagnostics division.
Find alternatives to RlapsRisk BC
What it does
- Medical imaging analysis
Features 3
- Combined image and clinical analysisCombines image analysis with age, number of invaded lymph nodes and tumor size.
- Prognostic region identificationDeep neural networks identify which image regions are most prognostic of high risk and give an initial report.
- IMS deploymentCan be deployed across existing IMS systems or IT settings.
Sources
- Pricing
-
Official documentation · 14 Sep 2026
Sold to hospitals/labs as a clinical diagnostic test; no public per-test price -- clinical procurement, not self-serve. Whether a recurring free tier exists is not stated either way.
- Description
- What it does
-
Official documentation · 29 Oct 2026
Reads pathology slide images: "Next-generation AI testing from routine H&E to inform the treatment pathway for early breast cancer patients"; the pathologist's slide is scanned into a whole slide image and read as "digitized H&E slides and clinical data". Same tag as TLS Detect.
- Sold within
-
Own page confirmed via waiv.com's own nav (after correcting a domain error -- waiv.ai is an unrelated boat-GPS company, confirmed against the existing waiv company record's website field). CE-IVDR cleared and sold clinically, but no self-serve rate or public price list found.
- Name
- URL
- Deployment
-
Official documentation · 29 Oct 2026
The test page does not state its delivery; Waiv's Destra page (https://waiv.com/precision-testing/destra) describes the platform that delivers all of Waiv's tests and lists "Scalable SaaS infrastructure" (Destra page, which describes itself as "a common platform enabling the easy access and use of all Waiv's digital pathology precision tests"). The test is run "in-browser through a web app" and its result returns "via a pdf within the pathologists existing workspace". Nothing on any of these pages describes running on the user's own device.
- Interfaces
-
Official documentation · 12 Oct 2026
Page: 'Using an in-browser web app, the user supplies the patient's age, number of invaded lymph nodes, and tumor size'.
- Modalities
-
Official documentation · 12 Oct 2026
Page: 'The slide is transformed into a whole slide image (WSI) via a slide scanner. / via a pdf within the pathologists existing workspace'.
- Intended for
Also from Waiv
-
BRCAura RUO Data service
Research-use-only AI test assessing BRCA-related genomic risk signatures from pathology data, sold to research institutions rather than clinical end users.
-
Destra Platform
Workflow platform that orchestrates Waiv's diagnostic tests within a lab's existing pathology workflow, handling sample intake, result delivery and reporting.
-
MSIntuit Suite Data service
Suite of AI tests that screen digitised H&E slides for microsatellite instability, marketed as one branded product line: the colorectal test (MSIntuit CRC) is CE-IVD marked, and the endometrial and gastric tests (MSIntuit EC and GC) are in development and research-use-only.
-
TLS Detect Data service
Research-use AI test that screens digitised H&E slides for tertiary lymphoid structures, a biomarker associated with response to immune checkpoint inhibitors, across tumour types and without a separate stain.
Something wrong here? Send a correction — quote this product id: waiv-rlapsrisk-bc.